About 3 400 reports

Cancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers

864 950 734

25 pages • By Venture Planning Group • Jul 2017

Cancer Diagnostic Instrumentation Review: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers

3500 3850 2975

119 pages • By Venture Planning Group • Jul 2017

Nucleic Acid Testing/NAT Instrumentation Review: Molecular Diagnostic Analyzers and Strategic Profiles of Leading Suppliers

3500 3850 2975

129 pages • By Venture Planning Group • Jul 2017

Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers

3182 3500 2705

286 pages • By Venture Planning Group • Jul 2017

Occult Blood Testing Market 2021: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities

2545 2800 2164

243 pages • By Venture Planning Group • Jul 2017

CA Tumor Markers Testing Market 2021: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities

3182 3500 2705

278 pages • By Venture Planning Group • Jul 2017

Global Cancer Diagnostics Market Overview 2021: Test Volume and Sales Forecasts by Country, Laboratory Universe

409 450 348

11 pages • By Venture Planning Group • Jul 2017

Tumor Markers Testing Instrumentation Review: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers

3500 3850 2975

119 pages • By Venture Planning Group • Jul 2017

Molecular Diagnostic Instrumentation Review and Strategic Profiles of Leading Suppliers

3500 3850 2975

103 pages • By Venture Planning Group • Jul 2017

Global Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

5682 6250 4830

320 pages • By Venture Planning Group • Jul 2017

Europe Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

4091 4500 3477

295 pages • By Venture Planning Group • Jul 2017

Latin America Asia-Pacific Nucleic Acid Testing (NAT) Analyzers and Reagents Market 2021: A 7-Country Analysis--Competitive Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review

4409 4850 3748

1150 pages • By Venture Planning Group • Jun 2017

Middle East Asia-Pacific Nucleic Acid Testing (NAT) Analyzers and Reagents Market 2021: An 11-Country Analysis--Competitive Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review

6818 7500 5795

1185 pages • By Venture Planning Group • Jun 2017

Spanish Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2273 2500 1932

521 pages • By Venture Planning Group • Jun 2017

US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

3818 4200 3245

567 pages • By Venture Planning Group • Jun 2017

French Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2273 2500 1932

533 pages • By Venture Planning Group • Jun 2017

UK Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2273 2500 1932

527 pages • By Venture Planning Group • Jun 2017

Italian Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2273 2500 1932

525 pages • By Venture Planning Group • Jun 2017

German Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2273 2500 1932

530 pages • By Venture Planning Group • Jun 2017

Japanese Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

3182 3500 2705

537 pages • By Venture Planning Group • Jun 2017

Chile Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

Qatar Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

Hong Kong Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

South Korea Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

Japan Tumor Markers Testing Market 2021: Supplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities

4455 4900 3786

590 pages • By Venture Planning Group • Jun 2017

Brazil Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

Iraq Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers

2955 3250 2511

535 pages • By Venture Planning Group • Jun 2017

Germany Tumor Markers Testing Market 2021: Supplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities

3955 4350 3361

585 pages • By Venture Planning Group • Jun 2017

Italy Tumor Markers Testing Market 2021: Supplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities

3955 4350 3361

570 pages • By Venture Planning Group • Jun 2017

Europe Tumor Markers Testing Market 2021: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities

11636 12800 9891

820 pages • By Venture Planning Group • Jun 2017